A New Generation of Targeted Therapies for Cancer, Autoimmune, and Infectious Diseases
We are exploring the use of high affinity targeting ligands to deliver attached drugs specifically into diseased cells, thereby simultaneously improving their potencies and reducing their off-target toxicities. For this purpose, we have designed targeting ligands for many human cancers, viruses and virus-infected cells, bone fracture surfaces, inflammatory macrophages, regulatory T cells, cancer associated fibroblasts, myeloid derived suppressor cells, antigen presenting cells, and tumor associated fibroblasts among others.
Organic Solar Cells and the Future Energy Challenge
Speaker: Thuc-Quyen Nguyen, Professor, Department of Chemistry & Biochemistry; Director, Center for Polymers and Organic Solids; University of California, Santa Barbara (UCSB) Friday, April 22, 2022, 8 am- 9 am | Zoom Meeting Abstract: The development of alternative energy sources is now recognized by government, society and the global community as an urgent need. Solution-processed organic solar
Global Cancer Research: Opportunities and Challenges
Speaker: Xiao-Ou Shu, M.D., MPH, Ph.D. Ingram Professor of Cancer Research, Professor of Medicine Associate Director for Global Health, Vanderbilt-Ingram Cancer Center, Co-Leader, Cancer Epidemiology Program, VICC Thursday, March 24, 2022, 8 pm- 9 pm | Zoom Meeting Abstract: Cancer is the second leading cause of death worldwide, claimed 10 million lives in 2020. Cancer incidence and